If you really want to break down the Pfizer deal with Excaliard which i personally still think is miles apart - diferent drugs, different targets & Excaliard having released positive data on their PhaseII trials (which did commence a little under 2 years ago) - but the structure of the deal is pretty much in line with most big pharmas agreements reached at that stage. A little up-front & more to gain further down the path as risk dissappears & the drug proves its validaty.
While no figures where directly released & remain confidential we can use assumptions of what is known - ISIS's equity stake in Excaliard was 10% or a little under, adjust the deal terms using 10% & then i guess you can assume it is slightly higher. All in all though pretty standard deal terms with royalties to add later provided the drug ever gets to market.
ISIS takes $4.4M up front = $44M Excaliard up front
ISIS has a further $9.6M potentially based on milestones.
Total 10% would equate to $14M - $140M for Excaliard
So up to IIb Pfizers put $44M on progress to date
- the rest is wait & see.
*** of course with no official figures released the assumptions could be a bit out but using what is publicly available it seems to paint a pretty standard picture.
> Just remember that is based on Excaliard's deal which is post Phase II & really has very little relevance to ANP apart from the ISIS link.
- Forums
- ASX - By Stock
- PER
- ballpark valuation
ballpark valuation, page-47
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PER (ASX) to my watchlist
(20min delay)
|
|||||
Last
13.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $117.2M |
Open | High | Low | Value | Volume |
13.5¢ | 14.0¢ | 13.0¢ | $168.5K | 1.260M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
8 | 633259 | 13.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
13.5¢ | 874939 | 7 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
8 | 633259 | 0.130 |
3 | 1437000 | 0.125 |
8 | 91409 | 0.120 |
5 | 1062287 | 0.115 |
5 | 322225 | 0.110 |
Price($) | Vol. | No. |
---|---|---|
0.135 | 874939 | 7 |
0.140 | 531203 | 7 |
0.145 | 205238 | 8 |
0.150 | 973514 | 8 |
0.155 | 122559 | 2 |
Last trade - 16.10pm 14/10/2024 (20 minute delay) ? |
Featured News
PER (ASX) Chart |
The Watchlist
I88
INFINI RESOURCES LIMITED
Charles Armstrong, Managing Director & CEO
Charles Armstrong
Managing Director & CEO
SPONSORED BY The Market Online